HOME › COMPANIES › SAREPTA THERAPEUTICS
LARGE / MID-CAP BIOPHARMA

SAREPTA THERAPEUTICS (SRPT)

Massachusetts, USA · North America
NEUROMUSCULAR
RARE DISEASES
LARGE / MID-CAP BIOPHARMA
HEADQUARTERS
Massachusetts, USA
TICKER
SRPT
SEGMENT
Large / Mid-cap Biopharma
THERAPY AREAS
Neuromuscular, rare diseases
KEY PRODUCTS
PRODUCTDETAILS
Exondys 51—
Vyondys 53—
COMPANY OVERVIEW

Biotech focused on Duchenne muscular dystrophy and other rare neuromuscular diseases.

SAREPTA THERAPEUTICS — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →